FARALLON CAPITAL MANAGEMENT LLC
Position in BEAM — Beam Therapeutics Inc.
CIK 909661
SAN FRANCISCO, CA
Position in BEAM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$351,313,110
+$109,803,305 QoQ
Shares Held
10,236,396
+1.0% QoQ
Ownership
9.91%
of shares outstanding
% of Portfolio
2.07%
of 13F equity value
Holder Rank
#2
of 274 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FARALLON CAPITAL MANAGEMENT LLC holds $7,178,355,833 across 25 Biotechnology names. BEAM ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
13,670,881 | $2,537,793,074 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
10,743,063 | $800,143,332 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
6,348,906 | $778,248,897 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,468,010 | $732,794,424 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
14,309,000 | $506,395,510 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
12,277,000 | $383,779,020 | |
| 7 | BEAM |
Beam Therapeutics Inc.
This page
|
10,236,396 | $351,313,110 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,989,098 | $336,372,047 |
All Filings in BEAM
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $351,313,110 | 10,236,396 | Shares | Other | 2026-08-14 | |
| 2026-06-30 | $352,885,447 | 10,282,210 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $241,509,805 | 10,134,696 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $278,949,436 | 10,063,111 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $244,231,703 | 10,063,111 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $170,323,018 | 10,013,111 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $193,896,007 | 9,928,111 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $204,330,250 | 8,239,123 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $201,099,013 | 8,208,123 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $185,404,471 | 7,913,123 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $149,068,319 | 4,511,753 | Shares | Other | 2024-05-24 | |
| 2023-12-31 | $111,758,596 | 4,105,753 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $107,788,227 | 4,481,839 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $109,887,797 | 3,441,522 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $105,085,421 | 3,431,921 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $132,970,910 | 3,399,921 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $172,993,750 | 3,631,271 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $134,411,610 | 3,472,271 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $148,658,375 | 2,594,387 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $180,501,436 | 2,265,045 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $149,447,505 | 1,717,590 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $193,065,000 | 1,500,000 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $47,422,179 | 592,481 | Shares | Other | 2021-05-17 | |
| 2020-03-31 | $3,062,952 | 170,164 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||